Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: The Augsburg diabetes family study

Diabetes Care

Volumn 30, Issue 4, 2007, Pages 946-952

  Kuch, Bernhard ^a   Von Scheidt, Wolfgang ^a   Peter, Wolfgang ^a   Döring, Angela ^b   Piehlmeier, Wolfgang ^c   Landgraf, Rüdiger ^c   Meisinger, Christa ^a,b  

^a KLINIKUM AUGSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADIPOSE TISSUE; AGED; BLOOD PRESSURE; BODY MASS INDEX; BODY SIZE; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GERMANY; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; REGRESSION ANALYSIS; RISK FACTORS; SEX CHARACTERISTICS; VENTRICULAR FUNCTION, LEFT;

EID: 34147099141     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2123     Document Type: Article

References (48)

1. Kannel WB, Gordon G, Offut D: Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med 71:89-105, 1969
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566, 1990
3. Casale PN, Devereux RB, Milner M: Value of echocardiographic left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105:173-178, 1986
4. Hammond IW, Devereux RB, Aldermann MH, Laragh JH: Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adult. J Am Coll Cardiol 12:996-1004, 1988
5. Lauer MS, Anderson KM, Levy D: Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 19:130-134, 1992
6. Messerli FH: Cardiovascular effects of obesity and hypertension. Lancet 1:1165-1168, 1982
7. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23:600-606, 1994
8. Kuch B, Muscholl M, Luchner A, Döring A, Riegger GAJ, Schunkert H, Hense HW: Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens 12:685-691, 1998
9. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Welty TK, Robbins DC, Fabsitz RR, Howard BV, Lee ET: Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study. Am Heart J 141:992-998, 2001
10. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV: Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 101:2271-2276, 2000
11. Chinali M, Devereux RB, Howard BW, Roman MJ, Bella JN, Liu JE, Resnick HE, Lee ET, Best LG, de Simone G: Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 93:40-44, 2004
12. Galderisi M, Anderson KM, Wilson PW, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68:85-89, 1991
13. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PWF, Vasan RS: Impact of glucose intolerance and insulin-resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107:448-454, 2003
14. Kuch B, von Scheidt W, Peter W, Heier M, Wichmann HE, Meisinger C: Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type 2 diabetes: the Augsburg Diabetes Family Study. J Hum Hypertens 20:757-764, 2006
15. Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H: Sex-differences in risk factors for incident type 2 diabetes: the MONICA Augsburg Cohort Study. Arch Intern Med 162:82-89, 2002
16. Eckel RH, Krauss RM, for the AHA Nutrition Committee: American Heart Association: call to action: obesity as a major risk factor for coronary heart disease. Circulation 97:2099-2100, 1998
17. Hense HW, Gneiting B, Muscholl M, Broeckel U, Kuch B, Döring A, Riegger GAJ, Schunkert H: The associations of body size and body composition with left ventricular mass: impacts for indexation in adults. J Am Coll Cardiol 32:451-457, 1998
18. Kuch B, Hense HW, Gneiting B, Döring A, Muscholl M, Bröckel U, Schunkert H: Body composition and prevalence of left ventricular hypertrophy. Circulation 102:405-410, 2000
19. Meisinger C, Löwel H, Thorand B, Döring A: Leisure time physical activity and the risk of type 2 diabetes in men and women from the general population: the MONICA/KORA Augsburg Cohort Study. Diabetologia 48:27-34, 2005
20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458, 1986
21. Schunkert H, Hense HW, Muscholl M, Luchner A, Kurzinger S, Danser AH, Riegger GA: Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 77:24-31, 1997
22. Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, Szklo M, Ward BJ: Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the Cardiovascular Health Study. Am Heart J 133:36-43, 1997
23. Kuch B, Schunkert H, Muscholl M, Doring A, von Scheidt W, Hense HW: Distribution, determinants and reference values of left ventricular parameters in the general population - results of the MONICA/KORA echocardiography studies. Gesundheitswesen 67 (Suppl 1):68-73, 2005
24. Ganau A, Devereux RB, Roman RJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550-1558, 1992
25. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
26. Majahalme S, Turjanmaa V, Weder A, Lu H, Tuomisto M, Virjo A, Uusitalo A: Blood pressure levels and variability, smoking, and left ventricular structure in normotension and in borderline and mild hypertension. Am J Hypertens 9:1110-1118, 1996
27. Bella JN, Devereux RB, Roman MJ, O'Grady MJ, Welty TK, Lee ET, Fabsitz RR, Howard BV: Relations of left ventricular mass to fat-free and adipose mass: the Strong Heart Study. Circulation 98:2538-2544, 1998
28. Karason K, Sjostrom L, Wallentin I, Peltonen M: Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure. Eur Heart J 24:1500-1505, 2003
29. Sato A, Tarnow L, Nielsen FS, Knudsen E, Parving H: Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment. Q J Med 98:879-884, 2005
30. Henry RM, Kamp O, Kostense PJ, Spijkerman AM, Dekker JM, van Eijck R, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study. Diabetes Care 27:522-529, 2004
31. De Simone G, Palmieri V, Bella JN, Ceelnatno A, Hong Y, Oberman A, Kitzman DW, Hopkins PN, Arnett DK: Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 20:323-331, 2002
32. Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahlof B, Gerdts E, Wright JT, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H, Devereux RB: Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study: Losartan Intervention for Endpoint Reduction. Am Heart J 143:319-326, 2002
33. Suzuki K, Kato K, Hanyu O, Nakagawa O, Aizawa Y: Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in type 2 diabetic patients. Diabetes Res Clin Pract 54:173-180, 2001
34. Boman K, Olofsson M, Dahlof B, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K, Devereux RB: Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study). Am J Cardiol 95:280-283, 2005
35. Sasson Z, Rasooly Y, Bhesania T, Rasooly I: Insulin-resistance is an important determinant of left ventricular mass in the obese. Circulation 88 (Pt 1):1431-1436, 1993
36. Sundstrom J, Lind L, Nystrom N, Zethelius B, Andren B, Hales CN, Lithell HO: Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin-resistance syndrome in elderly men. Circulation 101:2595-2600, 2000
37. Cabral AM, Vasquez EC, Moyses MR, Antonio A: Sex hormone modulation of ventricular hypertrophy in sinoaortic denervated rats. J Hypertens 2:85-91, 1984
38. du Cailar G, Ribstein J, Pasquie JL, Mimran A: Determinant of left ventricular hypertrophy in the hypertensive woman. Influence of hormone replacement therapy for menopause. Arch Mal Coeur Vaiss 92:975-977, 1999
39. Muscholl MW, Schunkert H, Muders F, Elsner D, Kuch B, Hense HW, Riegger GA: Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J 135:58-66, 1998
40. Peter I, Shearman AM, Vasan RS, Zucker DR, Schmid CH, Demissie S, Cupples LA, Kuvin JT, Karas RH, Mendelsohn ME, Housman DE, Benjamin EJ: Association of estrogen receptor β gene polymorphisms with left ventricular mass and wall thickness in women. Am J Hypertens 18:1388-1395, 2005
41. Vasan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, Murabito JM, Sam F, Colucci WS, Wilson PEF: Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 43:957-962, 2004
42. Uusitupa M, Siitonen O, Pyorala K, Mustonen J, Voutilainen E, Hersio K, Penttila I: Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects. Diabetes Res 4:19-25, 1987
43. Tenenbaum A, Fisman EZ, Schwammenthal E, Adler Y, Benderly M, Motro M, Shemesh J: Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus. Cardiovasc Diabetol 2:14, 2003
44. Hu G, DECODE Study Group: Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608-617, 2003
45. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035-2038, 1979
46. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M: Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 32:131-158, 2006
47. Krumholz HM, Larson M, Levy D: Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 25:879-884, 1995
48. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Howard BV: Associations of insulin levels with left ventricular structure and function in American Indians: the Strong Heart Study. Diabetes 51:1543-1547, 2002